Long-Term Intraocular Pressure Changes in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab

Publisher： Karger

E-ISSN： 1423-0267|229|3|168-172

ISSN： 0030-3755

Source： Ophthalmologica, Vol.229, Iss.3, 2013-03, pp. : 168-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

By  

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 231, Iss. 2, 2013-12 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Long-Term Effect of Anti-VEGF Agents on Intraocular Pressure in Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 56, Iss. 1, 2016-04 ,pp. : 30-34

Karger

Access to resources Recommend Favorite

Review of Ranibizumab Trials for Neovascular Age-Related Macular Degeneration

By Patel Ravi D.   Momi Rominder S.   Hariprasad Seenu M.  

Seminars in Ophthalmology, Vol. 26, Iss. 6, 2011-11 ,pp. : 372-379

Informa Healthcare

Access to resources Recommend Favorite

Does Ranibizumab (Lucentis®) Change Retrobulbar Blood Flow in Patients with Neovascular Age-Related Macular Degeneration?

By  

Ophthalmic Research, Vol. 47, Iss. 3, 2011-10 ,pp. : 141-145

Karger

Access to resources Recommend Favorite